Author

J. G. Schmidt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:protein sequence· 2 Approach:deep learning· 1 Approach:mechanistic / dynamical model· 1 Assay:structural biology· 1 Organism:virus· 1

Frequent Co-Authors

A. Brace· 1 shared A. Clyde· 1 shared A. Kovalevsky· 1 shared A. Merzky· 1 shared A. Ramanathan· 1 shared A. Trifan· 1 shared B. Blaiszik· 1 shared C. E. M. Strauss· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

A. Brace

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Configurational entropy-based screening and selection of hydrophilic polymers using the tripartite split green fluorescent protein

S. Banerjee, Y. Minko, E. S. Anaya, Z. J. Sasiene, J. G. Schmidt, C. E. M. Strauss, G. S. Waldo

The paper develops a tripartite GFP system to measure and isolate hydrophilic polymers based on configurational entropy, demonstrating its applicability to polypeptoids and potential for other polymers.

bioRxiv · Nov 7, 2022 · PreprintBiophysics

Peptide and protein alphavirus antigens for broad spectrum vaccine design

C. H. Schein, J. G. Schmidt, W. Braun, S. Weaver, W. S. Baker, G. Rafael, S. S. Negi

The paper designs and tests peptide and protein antigens from alphavirus envelope proteins to create broad-spectrum vaccines effective against multiple alphavirus species.

bioRxiv · May 26, 2022 · PreprintBioengineering

High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent Inhibitor

A. Clyde, S. Galanie, D. W. Kneller, H. Ma, Y. Babuji, B. Blaiszik, A. Brace, T. Brettin, K. Chard, R. Chard, L. Coates, I. Foster, D. Hauner, V. Kertesz, N. Kumar, , R. Stevens

This paper identifies a novel non-covalent inhibitor of SARS-CoV-2 main protease through high throughput virtual screening, validated by biochemical assays, X-ray crystallography, and molecular dynamics simulations.

bioRxiv · Mar 27, 2021 · PreprintBiophysics